1
|
Lin S, Gao M, Yang Z, Yu R, Dai Z, Jiang C, Yao Y, Xu T, Chen J, Huang K, Lin D. CT-Based Radiomics Models for Differentiation of Benign and Malignant Thyroid Nodules: A Multicenter Development and Validation Study. AJR Am J Roentgenol 2024:1-12. [PMID: 38691415 DOI: 10.2214/ajr.24.31077] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/03/2024]
Abstract
BACKGROUND. CT is increasingly detecting thyroid nodules. Prior studies indicated a potential role of CT-based radiomics models in characterizing thyroid nodules, although these studies lacked external validation. OBJECTIVE. The purpose of this study was to develop and validate a CT-based radiomics model for the differentiation of benign and malignant thyroid nodules. METHODS. This retrospective study included 378 patients (mean age, 46.3 ± 13.9 [SD] years; 86 men, 292 women) with 408 resected thyroid nodules (145 benign, 263 malignant) from two centers (center 1: 293 nodules, January 2018 to December 2022; center 2: 115 nodules, January 2020 to December 2022) who underwent preoperative multiphase neck CT (noncontrast, arterial, and venous phases). Nodules from center 1 were divided into training (n = 206) and internal validation (n = 87) sets; all nodules from center 2 formed an external validation set. Radiologists assessed nodules for morphologic CT features. Nodules were manually segmented on all phases, and radiomic features were extracted. Conventional (clinical and morphologic CT), noncontrast CT radiomics, arterial phase CT radiomics, venous phase CT radiomics, multiphase CT radiomics, and combined (clinical, morphologic CT, and multiphase CT radiomics) models were established using feature selection methods and evaluated by ROC curve analysis, calibration-curve analysis, and decision-curve analysis. RESULTS. The combined model included patient age, three morphologic features (cystic change, "edge interruption" sign, abnormal cervical lymph nodes), and 28 radiomic features (from all three phases). In the external validation set, the combined model had an AUC of 0.923, and, at an optimal threshold derived in the training set, sensitivity of 84.0%, specificity of 94.1%, and accuracy of 87.0%. In the external validation set, the AUC was significantly higher for the combined model than for the conventional model (0.827), noncontrast CT radiomics model (0.847), arterial phase CT radiomics model (0.826), venous phase CT radiomics model (0.773), and multiphase CT radiomics model (0.824) (all p < .05). In the external validation set, the calibration curves indicated the lowest (i.e., best) Brier score for the combined model; in the decision-curve analysis, the combined model had the highest net benefit for most of the range of threshold probabilities. CONCLUSION. A combined model incorporating clinical, morphologic CT, and multiphase CT radiomics features exhibited robust performance in differentiating benign and malignant thyroid nodules. CLINICAL IMPACT. The combined radiomics model may help guide further management for thyroid nodules detected on CT.
Collapse
Affiliation(s)
- Shaofan Lin
- Department of Radiology, Shantou Central Hospital, No. 114 Waima Rd, Shantou 515031, People's Republic of China
| | - Ming Gao
- Department of Radiology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, People's Republic of China
- Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Medical Research Center, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, People's Republic of China
| | - Zehong Yang
- Department of Radiology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, People's Republic of China
- Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Medical Research Center, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, People's Republic of China
| | - Ruihuan Yu
- Department of Radiology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, People's Republic of China
- Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Medical Research Center, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, People's Republic of China
| | - Zhuozhi Dai
- Department of Radiology, Shantou Central Hospital, No. 114 Waima Rd, Shantou 515031, People's Republic of China
| | - Chuling Jiang
- Department of Radiology, Shantou Central Hospital, No. 114 Waima Rd, Shantou 515031, People's Republic of China
| | - Yubin Yao
- Department of Radiology, Shantou Central Hospital, No. 114 Waima Rd, Shantou 515031, People's Republic of China
| | - Tingting Xu
- Department of Radiology, Shantou Central Hospital, No. 114 Waima Rd, Shantou 515031, People's Republic of China
| | - Jiali Chen
- Department of Radiology, Shantou Central Hospital, No. 114 Waima Rd, Shantou 515031, People's Republic of China
| | - Kainan Huang
- Department of Radiology, Shantou Central Hospital, No. 114 Waima Rd, Shantou 515031, People's Republic of China
| | - Daiying Lin
- Department of Radiology, Shantou Central Hospital, No. 114 Waima Rd, Shantou 515031, People's Republic of China
| |
Collapse
|
2
|
Wang M, Jiang H. PST-Radiomics: a PET/CT lymphoma classification method based on pseudo spatial-temporal radiomic features and structured atrous recurrent convolutional neural network. Phys Med Biol 2023; 68:235014. [PMID: 37956448 DOI: 10.1088/1361-6560/ad0c0f] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/23/2023] [Accepted: 11/13/2023] [Indexed: 11/15/2023]
Abstract
Objective.Existing radiomic methods tend to treat each isolated tumor as an inseparable whole, when extracting radiomic features. However, they may discard the critical intra-tumor metabolic heterogeneity (ITMH) information, that contributes to triggering tumor subtypes. To improve lymphoma classification performance, we propose a pseudo spatial-temporal radiomic method (PST-Radiomics) based on positron emission tomography computed tomography (PET/CT).Approach.Specifically, to enable exploitation of ITMH, we first present a multi-threshold gross tumor volume sequence (GTVS). Next, we extract 1D radiomic features based on PET images and each volume in GTVS and create a pseudo spatial-temporal feature sequence (PSTFS) tightly interwoven with ITMH. Then, we reshape PSTFS to create 2D pseudo spatial-temporal feature maps (PSTFM), of which the columns are elements of PSTFS. Finally, to learn from PSTFM in an end-to-end manner, we build a light-weighted pseudo spatial-temporal radiomic network (PSTR-Net), in which a structured atrous recurrent convolutional neural network serves as a PET branch to better exploit the strong local dependencies in PSTFM, and a residual convolutional neural network is used as a CT branch to exploit conventional radiomic features extracted from CT volumes.Main results.We validate PST-Radiomics based on a PET/CT lymphoma subtype classification task. Experimental results quantitatively demonstrate the superiority of PST-Radiomics, when compared to existing radiomic methods.Significance.Feature map visualization of our method shows that it performs complex feature selection while extracting hierarchical feature maps, which qualitatively demonstrates its superiority.
Collapse
Affiliation(s)
- Meng Wang
- Software College, Northeastern University, Shenyang 110819, People's Republic of China
| | - Huiyan Jiang
- Software College, Northeastern University, Shenyang 110819, People's Republic of China
- Key Laboratory of Intelligent Computing in Medical Image, Ministry of Education, Northeastern University, Shenyang 110819, People's Republic of China
| |
Collapse
|
3
|
Toro-Tobon D, Loor-Torres R, Duran M, Fan JW, Singh Ospina N, Wu Y, Brito JP. Artificial Intelligence in Thyroidology: A Narrative Review of the Current Applications, Associated Challenges, and Future Directions. Thyroid 2023; 33:903-917. [PMID: 37279303 PMCID: PMC10440669 DOI: 10.1089/thy.2023.0132] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 06/08/2023]
Abstract
Background: The use of artificial intelligence (AI) in health care has grown exponentially with the promise of facilitating biomedical research and enhancing diagnosis, treatment, monitoring, disease prevention, and health care delivery. We aim to examine the current state, limitations, and future directions of AI in thyroidology. Summary: AI has been explored in thyroidology since the 1990s, and currently, there is an increasing interest in applying AI to improve the care of patients with thyroid nodules (TNODs), thyroid cancer, and functional or autoimmune thyroid disease. These applications aim to automate processes, improve the accuracy and consistency of diagnosis, personalize treatment, decrease the burden for health care professionals, improve access to specialized care in areas lacking expertise, deepen the understanding of subtle pathophysiologic patterns, and accelerate the learning curve of less experienced clinicians. There are promising results for many of these applications. Yet, most are in the validation or early clinical evaluation stages. Only a few are currently adopted for risk stratification of TNODs by ultrasound and determination of the malignant nature of indeterminate TNODs by molecular testing. Challenges of the currently available AI applications include the lack of prospective and multicenter validations and utility studies, small and low diversity of training data sets, differences in data sources, lack of explainability, unclear clinical impact, inadequate stakeholder engagement, and inability to use outside of the research setting, which might limit the value of their future adoption. Conclusions: AI has the potential to improve many aspects of thyroidology; however, addressing the limitations affecting the suitability of AI interventions in thyroidology is a prerequisite to ensure that AI provides added value for patients with thyroid disease.
Collapse
Affiliation(s)
- David Toro-Tobon
- Division of Endocrinology, Diabetes, Metabolism and Nutrition, Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA
| | - Ricardo Loor-Torres
- Division of Endocrinology, Diabetes, Metabolism and Nutrition, Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA
| | - Mayra Duran
- Division of Endocrinology, Diabetes, Metabolism and Nutrition, Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA
| | - Jungwei W. Fan
- Department of Artificial Intelligence and Informatics, Mayo Clinic, Rochester, Minnesota, USA
| | - Naykky Singh Ospina
- Division of Endocrinology, Department of Medicine, University of Florida, Gainesville, Florida, USA
| | - Yonghui Wu
- Department of Health Outcomes and Biomedical Informatics, College of Medicine, University of Florida, Gainesville, Florida, USA
| | - Juan P. Brito
- Division of Endocrinology, Diabetes, Metabolism and Nutrition, Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA
| |
Collapse
|
4
|
Prediction of Central Lymph Node Metastasis in cN0 Papillary Thyroid Carcinoma by CT Radiomics. Acad Radiol 2022:S1076-6332(22)00493-7. [PMID: 36220726 DOI: 10.1016/j.acra.2022.09.002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/30/2022] [Revised: 08/22/2022] [Accepted: 09/02/2022] [Indexed: 11/23/2022]
Abstract
RATIONALE AND OBJECTIVES To explore the feasibility of the preoperative prediction of pathological central lymph node metastasis (CLNM) status in patients with negative clinical lymph node (cN0) papillary thyroid carcinoma (PTC) using a computed tomography (CT) radiomics signature. MATERIALS AND METHODS A total of 97 PTC cN0 nodules with CLNM pathology data (pN0, with CLNM, n = 59; pN1, without CLNM, n = 38) in 85 patients were divided into a training set (n = 69) and a validation set (n = 28). For each lesion, 321 radiomic features were extracted from nonenhanced, arterial and venous phase CT images. Minimum redundancy and maximum relevance and the least absolute shrinkage and selection operator were used to find the most important features with which to develop a radiomics signature in the training set. The performance of the radiomics signature was evaluated by receiver operating characteristic curves, calibration curves and decision curve analysis . RESULTS Three nonzero the least absolute shrinkage and selection operator coefficient features were selected for radiomics signature construction. The radiomics signature for distinguishing the pN0 and pN1 groups achieved areas under the curve of 0.79 (95% CI 0.67, 0.91) in the training set and 0.77 (95% CI 0.55, 0.99) in the validation set. The calibration curves demonstrated good agreement between the radiomics score-predicted probability and the pathological results in the two sets (p= 0.399, p = 0.191). The decision curve analysis curves showed that the model was clinically useful. CONCLUSION This radiomic signature could be helpful to predict CLNM status in cN0 PTC patients.
Collapse
|
5
|
A Novel -Gram-Based Image Classification Model and Its Applications in Diagnosing Thyroid Nodule and Retinal OCT Images. COMPUTATIONAL AND MATHEMATICAL METHODS IN MEDICINE 2022; 2022:3151554. [PMID: 35547561 PMCID: PMC9085325 DOI: 10.1155/2022/3151554] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 12/06/2021] [Revised: 04/14/2022] [Accepted: 04/16/2022] [Indexed: 11/18/2022]
Abstract
Imbalanced classes and dimensional disasters are critical challenges in medical image classification. As a classical machine learning model, the n-gram model has shown excellent performance in addressing this issue in text classification. In this study, we proposed an algorithm to classify medical images by extracting their n-gram semantic features. This algorithm first converts an image classification problem to a text classification problem by building an n-gram corpus for an image. After that, the algorithm was based on the n-gram model to classify images. The algorithm was evaluated by two independent public datasets. The first experiment is to diagnose benign and malignant thyroid nodules. The best area under the curve (AUC) is 0.989. The second experiment is to diagnose the type of fundus lesion. The best result is that it correctly identified 86.667% of patients with dry age-related macular degeneration (AMD), 93.333% of patients with diabetic macular edema (DME), and 93.333% of normal individuals.
Collapse
|